Ep. 107 - A Tale of Two Targets: LAG3, IL-2; Plus Alternatives to Cash Up
BioCentury This Week
00:00
The Byo Century Podcast - Stephen Usden
The executive team of candle paul, peter tugf and his c f o, jon catpa. What they said was that theyare hoping that this is a bridge that gets them to a position where the company's programs have generated more value. Look for it on thursday at the bio century show dot com.
Transcript
Play full episode
